SAN ANTONIO (MedPage Today) -- Patients with neuropathic cancer pain obtained consistent, long-term pain control with extended-release oxymorphone, according to results of a one-year open-label extension study...

AAPM: Opioid Shows Long-Term Control of Neuropathic Cancer Pain (click here for the full article at MedPage Today)